Abstract
Background: Inflammation‐induced procoagulant changes and alterations in platelet activity appear to play an important role in thromboembolic complications of infective endocarditis (IE).
Hypothesis: The aim of this study was to investigate systemic coagulation activity, fibrinolytic capacity, and platelet activation in patients with IE with and without embolic events by measuring the plasma levels of prothrombin fragment 1+2 (PF1+2), thrombin‐antithrombin III complex (TAT), plasminogen activator inhibitor‐1 (PAI‐1), beta‐thromboglobulin (3‐TG), and platelet factor 4 (PF4), respectively.
Methods: The study included 76 consecutive patients (female = 55, male = 21, mean age 26 years, range 8‐64 years) with definite IE according to the Duke criteria; of these, 13 (17.1%) had embolic events.
Results: Plasma concentrations of PF1+2 (3.2 ± 1.3 vs. 1.7 ± 0.7 and 1.4 ± 0.7 nmol/l, p < 0.001, respectively) and TAT (7.3 ± 1.5 vs. 2.9 ± 1.2 and 2.2 ± 1.1 ng/ml, p < 0.001, respectively) were elevated in patients with embolic events compared with patients without embolic events and control subjects. Similarly, patients with embolic events had increased plasma levels of (3‐TG 63.3 ± 10.9 vs. 33.1 ± 11.6 and 19.1 ± 10.6 ng/ml, p < 0.001, respectively) and PF4 (106.0 ± 28.7 vs. 50.3 ± 16.7 and 43.0 ± 15.8 ng/ml, p < 0.001, respectively) compared with those without embolic events and the control group. Embolic patients also had higher PAI‐1 levels than nonembolic patients and healthy subjects (14.4 ± 6.4 vs. 8.6 ± 5.9 and 5.4 + 4.3 ng/ml, p = 0.002, respectively).
Conclusion: Patients with IE and with subsequent thromboembolism have increased systemic coagulation activation, enhanced platelet activity/damage, and impaired fibrinolysis. The resulting imbalance produces a sustained hypercoagulable state, which contributes to the increased risk of thromboembolic events in this particular group.
Keywords: infective endocarditis, thromboembolism, coagulation activation, platelet activity
Full Text
The Full Text of this article is available as a PDF (33.2 KB).
References
- 1. Hart GH, Foster JW, Luther MF, Kanter MO: Stroke in infective endocarditis. Stroke 1990; 21: 695–700 [DOI] [PubMed] [Google Scholar]
- 2. Steckelberg JM, Murphy JG, Ballard D: Emboli in infective endocarditis: The prognostic value of echocardiography. Ann Intern Med 1991; 114: 635–640 [DOI] [PubMed] [Google Scholar]
- 3. Nissen H, Nielsen PF, Frederiksen M: Native valve infective endocarditis in the general population: A 10 year survey of the clinical picture during the 1980s. Eur Heart J 1992; 13: 872–877 [DOI] [PubMed] [Google Scholar]
- 4. Weinstein L, Schlesinger JJ: Patho‐anatomic, patho‐physiologic and clinical correlations in endocarditis. N Engl J Med 1974; 291: 832–837, 1122–1126 4608722 [Google Scholar]
- 5. Buda AJ, Zotz RJ, LeMire MS, Bach DS: Prognostic signiFICAnce of vegetations detected by two‐dimensional echocardiography in infective endocarditis. Am Heart J 1986; 112: 1291–1296 [DOI] [PubMed] [Google Scholar]
- 6. Sanfilippo AJ, Picard MH, Newell JB: Echocardiographic assessment of patients with infective endocarditis: Prediction of risk for complications. J Am Coll Cardiol 1991; 18: 1191–1199 [DOI] [PubMed] [Google Scholar]
- 7. Valtonen V, Kuikka A, Syrjanen J: Thromboembolic complications in bacteremic infections. Eur Heart J 1993; 14 (suppl K): 20–23 [PubMed] [Google Scholar]
- 8. Syrjanen J: Infection as a risk factor for cerebral infarction. Eur Heart J 1993; 14 (suppl K): 17–19 [PubMed] [Google Scholar]
- 9. Macko RF, Ameriso SF, Barndt R: Precipitants of brain infarction: Roles of preceding infection/inflammation and recent psychological stress. Stroke 1996; 27: 1999–2004 [DOI] [PubMed] [Google Scholar]
- 10. Bone RC: Modulators of coagulation. A critical appraisal of their role in sepsis. Arch Intern Med 1992; 152: 1381–1389 [DOI] [PubMed] [Google Scholar]
- 11. Durack DT, Lukes AS, Bright DK: New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Am J Med 1994; 96: 200–209 [DOI] [PubMed] [Google Scholar]
- 12. Shapiro SM, Young E, De Guzman S: Transesophageal echocardiography in the diagnosis of infective endocarditis. Chest 1994; 105: 377–382 [DOI] [PubMed] [Google Scholar]
- 13. De Meyer GRY, Herman AG: Vascular endothelial dysfunction. Prog Cardiovasc Dis 1997; 39: 4: 325–342 [DOI] [PubMed] [Google Scholar]
- 14. Munro JM: Endothelial‐leukocyte adhesive interactions inflammatory disease. Eur Heart J 1993; 14 (suppl K): 72–77 [PubMed] [Google Scholar]
- 15. McGill SN, Ahmed NA, Christou NV: Increased plasma von Willebrand factor in the systemic inflammatory response syndrome is derived from generalised endothelial cell activation. Crit Care Med 1998; 26: 296–300 [DOI] [PubMed] [Google Scholar]
- 16. Thomas AD, Pang M: Staphylococcus aureus induces tissue factor expression in cultured human cardiac valve endothelium. J Infect Dis 1988; 157: 749–756 [DOI] [PubMed] [Google Scholar]
- 17. Bancsi MJLMF, Thompson J, Bertina RM: Stimulation of monocyte tissue factor expression in an in vitro model of bacterial endocarditis. Infect Immun 1994; 62: 5669–5672 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Drake TA, Pang M: Effects of interleukin‐1, lipopolysaccharide and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells. Infect Immun 1989; 57: 507–512 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Buiting AGM, Thompson J, van der Keur D, Schmal‐Bauer WC, Bertina RM: Procoagulant activity of endocardial vegetations and blood monocytes in rabbits with Streptococcus sanguis endocarditis. Thromb Haemostas 1989; 62: 1029–1033 [PubMed] [Google Scholar]
- 20. Bancsi MJLMF, Veltrop MHAM, Bertina RM, Thompson J: Role of phagocytosis in activation of the coagulation system in Streptococcus san‐guis endocarditis. Infect Immun 1996; 64: 5166–5170 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Kupferwasser LI, Hafner G, Kahaly SM, Erbel R, Meyer J, Darius H: The presence of infection‐related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events. J Am Coll Cardiol 1999; 33: 1365–1371 [DOI] [PubMed] [Google Scholar]
- 22. De Meyer GRY, Herman AG: Vascular endothelial dysfunction. Prog Cardiovasc Dis 1997; 39: 4: 325–342 [DOI] [PubMed] [Google Scholar]
- 23. Korkmaz S, Ileri M, Hisar I, Yetkin E, Kosar F: Increased levels of soluble adhesion molecules, E‐selectin and P‐selectin in patients with infective endocarditis and embolic events. Eur Heart J 2001; 22: 874–878 [DOI] [PubMed] [Google Scholar]
- 24. Krithof EKO: Plasminogen activator inhibitor type 1. Biochemical, biological and clinical aspects. Fibrinolysis 1988;(suppl 2): 59
- 25. Juhan‐Vague I, Valadier J, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C: Deficient tPA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemost 1987; 57: 67–76 [PubMed] [Google Scholar]
- 26. Ailland MF, Juhan‐Vague F, Alessi MC, Marecal M, Vinson MF, Arnaud C, Vague P, Colen D: Increased PA‐inhibitor levels in the postoperative period–No cause–effect relation with increased cortisol. Thromb Haemost 1985; 54: 466–472 [PubMed] [Google Scholar]
- 27. De Jong E, Knot EAR, Piket D, Iburg A, Rijken D, Veenhof K, Dooijjewaard G, Ten Cate J: Increased plasminogen activator inhibition levels in malignancy. Thromb Haemost 1987; 57: 140–145 [PubMed] [Google Scholar]
- 28. Clawson CC, Rao GHR, White JG: Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol 1975; 81: 411–420 [PMC free article] [PubMed] [Google Scholar]
- 29. Kuspiewski GE, Forrester LJ, Campbell BJ, Barett JT: Platelet aggregation by Streptococcus pyogenes . Infect Immun 1983; 39: 704–708 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Kessler CM, Nussbaum E, Tuazon CU: In vitro correlation of platelet aggregation with occurrence of disseminated intravascular coagulation and subacute bacterial endocarditis. J Lab Clin Med 1987; 109: 647–652 [PubMed] [Google Scholar]